FR2361104B2 - - Google Patents

Info

Publication number
FR2361104B2
FR2361104B2 FR7701501A FR7701501A FR2361104B2 FR 2361104 B2 FR2361104 B2 FR 2361104B2 FR 7701501 A FR7701501 A FR 7701501A FR 7701501 A FR7701501 A FR 7701501A FR 2361104 B2 FR2361104 B2 FR 2361104B2
Authority
FR
France
Prior art keywords
hereinafter defined
pellet
medicament
cms
pellets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7701501A
Other languages
English (en)
French (fr)
Other versions
FR2361104A2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB260676A external-priority patent/GB1569611A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of FR2361104A2 publication Critical patent/FR2361104A2/fr
Application granted granted Critical
Publication of FR2361104B2 publication Critical patent/FR2361104B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7701501A 1976-01-23 1977-01-20 Medicament sous forme de grains friables Granted FR2361104A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB260876 1976-01-23
GB260676A GB1569611A (en) 1976-01-23 1976-01-23 Pelletised or granular medicament formulation

Publications (2)

Publication Number Publication Date
FR2361104A2 FR2361104A2 (fr) 1978-03-10
FR2361104B2 true FR2361104B2 (enExample) 1982-09-17

Family

ID=26237614

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7701501A Granted FR2361104A2 (fr) 1976-01-23 1977-01-20 Medicament sous forme de grains friables

Country Status (12)

Country Link
JP (1) JPS5294413A (enExample)
AU (1) AU506878B2 (enExample)
CA (1) CA1116516A (enExample)
DK (1) DK27177A (enExample)
ES (1) ES455273A1 (enExample)
FI (1) FI67663C (enExample)
FR (1) FR2361104A2 (enExample)
IE (1) IE45260B1 (enExample)
LU (1) LU76618A1 (enExample)
NO (1) NO148542C (enExample)
SE (1) SE442950B (enExample)
ZA (1) ZA77327B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072046B1 (en) * 1981-07-24 1986-01-15 FISONS plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
US6102036A (en) * 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler
BR112019010069A2 (pt) 2016-12-08 2019-08-20 R.P. Scherer Technologies, Llc método para aliviar tensão em carcaças de cápsula para reduzir propensão à ruptura

Also Published As

Publication number Publication date
FI67663B (fi) 1985-01-31
AU2158977A (en) 1978-08-03
NO770198L (no) 1977-07-26
JPS5294413A (en) 1977-08-09
ZA77327B (en) 1977-12-28
NO148542C (no) 1983-11-02
CA1116516A (en) 1982-01-19
FI770070A7 (enExample) 1977-07-24
SE442950B (sv) 1986-02-10
DK27177A (da) 1977-07-24
FR2361104A2 (fr) 1978-03-10
IE45260L (en) 1977-07-23
AU506878B2 (en) 1980-01-24
LU76618A1 (enExample) 1977-08-12
IE45260B1 (en) 1982-07-28
JPS6228124B2 (enExample) 1987-06-18
FI67663C (fi) 1985-05-10
NO148542B (no) 1983-07-25
SE7700665L (sv) 1977-07-24
ES455273A1 (es) 1978-04-01

Similar Documents

Publication Publication Date Title
ES8500739A1 (es) Metodo de producir composiciones farmaceuticas de liberacion controlada y accion prolongada
PT81039A (en) Process for preparing pellet formulations
AU563740B2 (en) Magnesium trisilicate adsorbate
DE3173892D1 (en) Insecticidal (1,1'-biphenyl)-3-ylmethyl esters, their production and use and compositions containing them
Eskilson Controlled release by microencapsulation.
Katyare et al. Heterogeneity of rat liver mitochondrial fractions and the effect of tri-iodothyronine on their protein turnover
AU4245289A (en) Psyllium-containing products
Grossie et al. Thyroxine secretion rates during food restriction in rats.
SE7700665L (sv) Forfarande for framstellning av en lekemedelskomposition
JPS565452A (en) Urea particle having improved characteristics and its manufacture
CA2023815A1 (en) Riboflavin granules containing no inactive ingredient
GR3004434T3 (enExample)
DE3474024D1 (en) Contraceptive compositions based on esters of levo-norgestrel
ES526874A0 (es) Procedimiento de trituracion de compuestos esteroides
ES8100343A1 (es) Un procedimiento para obtener un producto de tripolifosfato sodico granular
SU1764213A1 (ru) Состав для предотвращения и тушения пожаров в замкнутых объемах
GR3001167T3 (en) Process for the preparation of a compressible granulate from celiprolol hydrochloride, free of binders
IE45690L (en) High density sodium cromoglycate
EP0370532A3 (en) Slow release oxamide fertilizer
JPS55122723A (en) Drug for asthma
Schwalm Behavior of Special Populations in Fires
JPS57112311A (en) Agricultural and horticultural germicidal composition
Noda et al. Primary effect of staphylococcal leukocidin on the destruction of rabbit polymorphonuclear leukocytes.
Naguib et al. Effect of initial counts of Staphylococcus aureus in Ras cheese-milk on its survival rates.
JPS5618906A (en) Agricultural and horticultural germicide

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name